Skip to content

Clinical Evaluation of Hydrogel and Silicone Hydrogel Daily Disposable Toric Contact Lenses

Clinical Evaluation of Biomedics 1 Day Toric and MyDay Toric

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05805085
Enrollment
40
Registered
2023-04-07
Start date
2023-01-10
Completion date
2023-11-16
Last updated
2024-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

This study was to evaluate the patient subjective experiences of two daily disposable toric contact lenses.

Detailed description

This was a participant masked, interventional, prospective, direct refit, bilateral wear study. The purpose of this study was to evaluate the patient subjective experiences of a hydrogel daily disposable toric contact lens when compared to a silicone hydrogel daily disposable toric contact lens after 15 minutes of daily wear each.

Interventions

DEVICELens A

Hydrogel Daily Disposable Toric Contact Lens for 15 minutes

DEVICELens B

Silicone Hydrogel Daily Disposable Toric Contact Lens for 15 minutes

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

A person was eligible for inclusion in the study if he/she: * Is at least 18 years of age and has full legal capacity to volunteer. * Has read and signed an information consent letter. * Self-reports having a full eye examination in the previous two years. * Anticipates being able to wear the study lenses for at least 8 hours a day, 5 days a week. * Is willing and able to follow instructions and maintain the appointment schedule. * Habitual soft contact lens wearers who currently wear toric contact lenses, or use spectacles for all distances vision correction, for the past 3 months minimum. * Has a contact lens spherical prescription between plano to - 10.00 (inclusive) best corrected visual acuity of 20/30 or better in either eye. * Has refractive astigmatism no less than -0.75D and no more than 1.75D in both eyes. * Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye. * Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses. * Has clear corneas and no active ocular disease. * Has read, understood, and signed the information consent letter.

Exclusion criteria

A person was excluded from the study if he/she: 1. Is participating in any concurrent clinical or research study. 2. Has any known active ocular disease and/or infection that contraindicates contact lens wear. 3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable. 4. Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable. 5. Has known sensitivity to the diagnostic sodium fluorescein used in the study. 6. Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment. 7. Has undergone refractive error surgery or intraocular surgery.

Design outcomes

Primary

MeasureTime frameDescription
Subjective Handling at Insertion, Dispensing Visit15 minutesSubjective handling an lens insertion was assessed at the dispending visit using a 0-100 scale, where 100=Excellent, very easy; 0=Very difficult to manage. Collected once at the end of 15 minutes of wear.
Subjecting Handling at Insertion, Follow-up Visit15 minutesSubjective handling at lens insertion was assessed at the follow-up visit using a 0-100 scale, where 100=Excellent, very easy; 0=Very difficult to manage. Collected once at the end of 15 minutes of wear.

Countries

Spain

Participant flow

Participants by arm

ArmCount
All Study Participants
Includes study participants that completed all study visits
40
Total40

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous
Female
27.08 years
STANDARD_DEVIATION 6.17
Age, Continuous
Male
27.10 years
STANDARD_DEVIATION 6.04
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
27 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 400 / 40
other
Total, other adverse events
0 / 400 / 40
serious
Total, serious adverse events
0 / 400 / 40

Outcome results

Primary

Subjecting Handling at Insertion, Follow-up Visit

Subjective handling at lens insertion was assessed at the follow-up visit using a 0-100 scale, where 100=Excellent, very easy; 0=Very difficult to manage. Collected once at the end of 15 minutes of wear.

Time frame: 15 minutes

ArmMeasureValue (MEAN)Dispersion
Lens ASubjecting Handling at Insertion, Follow-up Visit92.63 score on a scaleStandard Deviation 9.28
Lens BSubjecting Handling at Insertion, Follow-up Visit90.13 score on a scaleStandard Deviation 9.97
Primary

Subjective Handling at Insertion, Dispensing Visit

Subjective handling an lens insertion was assessed at the dispending visit using a 0-100 scale, where 100=Excellent, very easy; 0=Very difficult to manage. Collected once at the end of 15 minutes of wear.

Time frame: 15 minutes

ArmMeasureValue (MEAN)Dispersion
Lens ASubjective Handling at Insertion, Dispensing Visit87.13 score on a scaleStandard Deviation 13.68
Lens BSubjective Handling at Insertion, Dispensing Visit88.50 score on a scaleStandard Deviation 10.14

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026